Page speed for SEO is no longer a nice-to-have checkbox on a technical audit list. It is a direct ranking factor, a conv ...

As Asia grappled with the impact of the Iran war, a major pharmaceutical milestone quietly made the headlines. On March 20, the patent for semaglutide, the active ingredient in Novo Nordisk’s Ozempic ...

These days, just about everyone is recommending a different way to lose weight. Whether it’s the latest ultra-low-fat diet, high-intensity exercise regimes like CrossFit or medications injected weekly ...

April 10 (Reuters) - Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23AndMe. The ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness before being sold or marketed. Talk to a healthcare professional about whether a supplement ...

Indian clinics market pre-wedding weight-loss packages with Mounjaro and Wegovy India obesity drugs market seen reaching $860.34 million by 2030 Drug regulator raises concerns over potential misuse as ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. INDIANAPOLIS, INDIANA - MARCH 17: A flag flies above the headquarters campus of Eli Lilly ...

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...

People who reach a healthy weight and improve their metabolic health on GLP-1 medications are typically told they’ll need to maintain a weekly dose indefinitely to keep the weight off. But emerging ...

Bookmarks break, this extension makes sure mine never do.